- Home
- WLDS vs KLTOW Comparison
WLDS vs KLTOW Comparison
Compare WLDS & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- KLTOW
- Stock Information
- Founded
- WLDS 2014
- KLTOW N/A
- Country
- WLDS Israel
- KLTOW United States
- Employees
- WLDS N/A
- KLTOW 3
- Industry
- WLDS Computer Communications Equipment
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WLDS Telecommunications
- KLTOW Health Care
- Exchange
- WLDS Nasdaq
- KLTOW Nasdaq
- Market Cap
- WLDS N/A
- KLTOW N/A
- IPO Year
- WLDS 2022
- KLTOW 2022
- Fundamental
- Price
- WLDS $1.62
- KLTOW $0.02
- Analyst Decision
- WLDS
- KLTOW
- Analyst Count
- WLDS 0
- KLTOW 0
- Target Price
- WLDS N/A
- KLTOW N/A
- AVG Volume (30 Days)
- WLDS 139.3K
- KLTOW N/A
- Earning Date
- WLDS 12-24-2024
- KLTOW N/A
- Dividend Yield
- WLDS N/A
- KLTOW N/A
- EPS Growth
- WLDS N/A
- KLTOW N/A
- EPS
- WLDS N/A
- KLTOW N/A
- Revenue
- WLDS $522,000.00
- KLTOW N/A
- Revenue This Year
- WLDS N/A
- KLTOW N/A
- Revenue Next Year
- WLDS N/A
- KLTOW N/A
- P/E Ratio
- WLDS N/A
- KLTOW N/A
- Revenue Growth
- WLDS 536.59
- KLTOW N/A
- 52 Week Low
- WLDS $1.65
- KLTOW N/A
- 52 Week High
- WLDS $54.40
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- WLDS 39.00
- KLTOW N/A
- Support Level
- WLDS $1.44
- KLTOW N/A
- Resistance Level
- WLDS $3.10
- KLTOW N/A
- Average True Range (ATR)
- WLDS 0.40
- KLTOW 0.00
- MACD
- WLDS 0.00
- KLTOW 0.00
- Stochastic Oscillator
- WLDS 10.98
- KLTOW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.